Effect of injection of transamine amine in reducing bleeding

Evaluation of the effect of injection of transamine amine in reducing bleeding following PCNL surgery in Shahid Hasheminejad Hospital

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171128037664N1

Enrollment

100

Registered

2018-02-10

Start date

2018-02-04

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone. Calculus of kidney and ureter

Interventions

Intervention 1: Intervention group: Injection 15 mg / kg body weight during anesthesia and 3 doses of 500 mg injectable with an interval of 8 hours in the ward. Intervention 2: Intervention group: Inj

Eligibility

Sex/Gender

All

Age

15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients of PCNL Adult patient

Exclusion criteria

Exclusion criteria: Disorders of color recognition Any allergic reaction to transamine compounds Taking an anti-coagulant medicine History of subarachnoid hemorrhage Liver Dysfunction Kidney failure

Design outcomes

Primary

Measure	Time frame
Bleeding. Timepoint: 6,24 and 48 hour after tranexamic acid. Method of measurement: CBC.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmojtaba ameli

Iran University of Medical Sciences

mojtaba.ameli@gmail.com+98 21 8864 4458

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026